Manipal Health Enterprises Limited has appointed Sathish K R as its Compliance Officer, effective November 25, 2025. The company filed the intimation with the Bombay Stock Exchange and National Stock Exchange on August 5, 2026, confirming that Sathish K R continues to hold the position in adherence to regulatory governance standards. This appointment ensures continuity in the firm’s compliance infrastructure, a critical function for maintaining investor trust and regulatory alignment in the healthcare sector.

The disclosure was submitted under Regulation 6(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Additionally, the filing includes details mandated by SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026, dated January 30, 2026. These references highlight the company’s structured approach to statutory disclosures and its commitment to transparent corporate governance practices.

Sathish K R, who holds ICSI Membership No. A15203, serves concurrently as the Company Secretary and General Counsel of Manipal Health Enterprises Limited. He has been associated with the company since August 14, 2019, overseeing regulatory strategy, legal compliance, and corporate governance functions. His dual role facilitates integrated oversight of legal and compliance matters, ensuring consistent interpretation of evolving regulatory requirements.

With over 25 years of experience in legal, company secretarial, and compliance domains, Sathish K R brings extensive industry knowledge to his role. He holds a bachelor’s degree in law from Bengaluru University and a master’s degree in law with distinction in commercial and corporate law from Queen Mary and Westfield College, University of London. Prior to joining Manipal Health Enterprises Limited, he worked with prominent organizations including Bosch Limited, GE Bayer Silicones (India) Private Limited, Essilor Manufacturing India Private Limited, and Siemens VDO Automotive Limited.

Governance Continuity

The retention of Sathish K R as Compliance Officer reflects stability in the company’s governance structure. His long-standing association with the firm since 2019 provides institutional memory and consistent interpretation of evolving regulatory requirements. For investors, this continuity signals a mature compliance infrastructure capable of navigating complex regulatory landscapes without disruption. The explicit mention of his qualifications and prior experience in the filing further reinforces the credibility of the company’s internal controls.

The Board of Directors of manipal health enterprises limited has authorized its Key Managerial Personnel (KMPs) to determine the materiality of events or information and make the requisite disclosures to stock exchanges. This decision streamlines the company's compliance process under Regulation 30(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. By delegating this authority, the company ensures timely dissemination of material information to investors while adhering to regulatory frameworks.

This authorization applies to four senior executives who will now jointly assess whether specific events or information meet the threshold for public disclosure. The move aligns with the company’s Policy on Determination of Materiality of Events or Information. The intimation was submitted to BSE Limited and the National Stock Exchange of India Limited on August 5, 2026.

Authorized Key Managerial Personnel

The following executives have been granted the authority to determine materiality:

Dilip Jose serves as the Managing Director and Chief Executive Officer, providing strategic oversight for these determinations. Sameer Agarwal acts as the Chief Financial Officer, bringing financial expertise to the assessment of materiality. Karthik Rajagopal, the Chief Operating Officer, contributes operational insights. Sathish K R, the Company Secretary and Compliance Officer, ensures that all disclosures comply with regulatory requirements.

Regulatory Context

Regulation 30 of the SEBI Listing Regulations mandates listed entities to promptly disclose any price-sensitive information to stock exchanges. Paragraph 5 of Regulation 30 allows companies to delegate the determination of materiality to their Board or a committee thereof, or to Key Managerial Personnel. Manipal Health Enterprises Limited has chosen the latter approach, empowering its top management to act swiftly in identifying and disclosing material events.

The details of these authorized personnel are available on the company’s website for transparency. This structure aims to enhance the efficiency of corporate communications and ensure that stakeholders receive accurate and timely information regarding significant developments affecting the company.

What the Numbers Show

While this filing does not contain financial metrics, the delegation of materiality determination reflects a governance choice to centralize disclosure decisions within the executive team. This can lead to faster response times to emerging events compared to requiring full Board approval for each assessment. The inclusion of both operational (Karthik Rajagopal) and financial (Sameer Agarwal) leaders alongside the CEO suggests a holistic approach to evaluating what constitutes material information for investors.